375 related articles for article (PubMed ID: 23609180)
1. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
2. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
Li C; Wang W; Xie L; Luo X; Cao X; Wan M
Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
[TBL] [Abstract][Full Text] [Related]
6. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
7. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.
Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
J Bone Miner Res; 2011 Sep; 26(9):2026-35. PubMed ID: 21590742
[TBL] [Abstract][Full Text] [Related]
8. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.
Yu B; Zhao X; Yang C; Crane J; Xian L; Lu W; Wan M; Cao X
J Bone Miner Res; 2012 Sep; 27(9):2001-14. PubMed ID: 22589223
[TBL] [Abstract][Full Text] [Related]
10. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
11. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
Saito H; Gasser A; Bolamperti S; Maeda M; Matthies L; Jähn K; Long CL; Schlüter H; Kwiatkowski M; Saini V; Pajevic PD; Bellido T; van Wijnen AJ; Mohammad KS; Guise TA; Taipaleenmäki H; Hesse E
Nat Commun; 2019 Mar; 10(1):1354. PubMed ID: 30902975
[TBL] [Abstract][Full Text] [Related]
12. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
13. The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.
Kawano T; Troiano N; Adams DJ; Wu JJ; Sun BH; Insogna K
Endocrinology; 2008 Aug; 149(8):4009-15. PubMed ID: 18467443
[TBL] [Abstract][Full Text] [Related]
14. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
15. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
16. NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH.
St-Arnaud R; Pellicelli M; Ismail M; Arabian A; Jafarov T; Zhou CJ
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055125
[TBL] [Abstract][Full Text] [Related]
17. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone signaling through low-density lipoprotein-related protein 6.
Wan M; Yang C; Li J; Wu X; Yuan H; Ma H; He X; Nie S; Chang C; Cao X
Genes Dev; 2008 Nov; 22(21):2968-79. PubMed ID: 18981475
[TBL] [Abstract][Full Text] [Related]
19. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
[TBL] [Abstract][Full Text] [Related]
20. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
